Type1 Diabetes Mellitus
Metabolic Diseases
1
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Novo NordiskBAGSVAERD DENMARK, Denmark
2 programs1
AspartPhase 41 trial
Continuous Glucose MonitorN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Novo NordiskAspart
InsuletInsulet automated glucose control system
Novo NordiskContinuous Glucose Monitor
Clinical Trials (3)
Total enrollment: 139 patients across 3 trials
Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump
Start: Apr 2018Est. completion: Nov 202059 patients
Phase 4Completed
Insulet Artificial Pancreas Free-Living IDE3
Start: Feb 2019Est. completion: May 2019
N/ACompleted
Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes
Start: Apr 2017Est. completion: Mar 201980 patients
N/ACompleted
Related Jobs in Metabolic Diseases
Manager, Patient Safety and Pharmacovigilance Operations
Kailera Therapeutics
Waltham, Massachusetts
11h ago
Senior Medical Science Liaison - Obesity - Northern CA, Central CA, NV
Amgen
California - San Francisco, US
Yesterday
(Sr) Scientist Analytical Chemistry – Mass Spectrometry (Temporary role 3 years)
Johnson & Johnson
Beerse, Antwerp, Belgium
2d ago
Computational Chemist
Topos Bio
San Francisco Office
2d ago
Associate Director, Legal Operations & Contracts Management
Kailera Therapeutics
Massachusetts
4d ago
From $155K/yr
Application & Integration Architect
Roche
Indianapolis
5d ago
$106K - $196K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space